TNXPTonix Pharmaceuticals Holding Corp.
12.55USD-1.41%Mkt Cap: 215.25M $P/E: —3d ago
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, an…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap215.25M $
Enterprise Value37.54M $
Revenue (TTM)29.10M $
Gross Profit6.47M $
Net Income (TTM)-124.02M $
Revenue/Share2.276 USD
Last Price12.55 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.57
PEG—
EV/EBITDA-0.23
EV/Revenue1.29
P/S7.30
P/B0.77
EPS (TTM)-12.70
EPS (Forward)-7.88
52W Range
9.4007% of range53.55
52W High53.55 USD
52W Low9.400 USD
Profitability
Gross Margin49.34%
Oper. Margin-314.05%
EBITDA Margin0.00%
Profit Margin-946.22%
ROE-50.59%
ROA-44.75%
Growth
Revenue Growth577.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-99.84M $
CapEx (TTM)3.37M $
FCF Margin-329.05%
FCF Yield-44.49%
Net Debt-174.96M $
Net Debt/EBITDA1.07
Balance Sheet
Debt/Equity0.01
Current Ratio6.61
Quick Ratio6.12
Book Value/Sh15.99 USD
Cash/Share10.28 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 1, 2019
Splits
Last Split1:100
Split DateFeb 5, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)42.40 USD
Upside (mean)+237.8%
Target Range22.00 USD – 65.00 USD
$22.00+237.8% to mean$65.00
# Analysts5
Ownership
Shares Out.17.15M
Float14.12M
Insiders0.13%
Institutions56.08%
Short Interest
Short Ratio7.3d
Short % Float21.47%
Short % Out.21.45%
Shares Short3.60M
Short (prev mo.)3.58M
Technical
SMA 5011.75 (+6.8%)
SMA 20014.32 (-12.4%)
Beta1.69
S&P 52W Chg18.16%
Avg Vol (30d)517.79K
Avg Vol (10d)529.80K
Technical Indicators
RSI (14)57.6
MACD0.3225
MACD Signal0.1216
MACD Hist.+0.2008
BB Upper13.64 USD
BB Middle11.36 USD
BB Lower9.089 USD
BB Width40.04%
ATR (14)0.8352 USD
Vol Ratio (20d)0.75x